Advertisement

Topics

"Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medication Database: Page 2

06:13 EDT 19th March 2019 | BioPortfolio

Here are the most relevant "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications that we have found in our database.

More Information about "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" on BioPortfolio

We have published hundreds of Ovid Therapeutics Reports Third Quarter 2017 Financial Results news stories on BioPortfolio along with dozens of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Clinical Trials and PubMed Articles about Ovid Therapeutics Reports Third Quarter 2017 Financial Results for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Companies in our database. You can also find out about relevant Ovid Therapeutics Reports Third Quarter 2017 Financial Results Drugs and Medications on this site too.

Showing "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications 26–50 of 57

Possibly Relevant

Diclofenac sodium [cambridge therapeutics technologies, llc]

Diclofenac Sodium Delayed-release Tablets, USP

Mitosol [mobius therapeutics llc]

These highlights do not include all the information needed to use Mitosol safely and effectively. See full prescribing information for Mitosol. Mitosol (mitomycin for solution) for ophthalmic useInitial U.S. Approval: 1974

Tobramycin [proficient rx lp]

Rx Only For Topical Ophthalmic Use Only

Tobramycin [preferred pharmaceuticals inc.]

Rx Only For Topical Ophthalmic Use Only

Tobramycin [remedyrepack inc.]

Rx Only For Topical Ophthalmic Use Only

Tri-vite drops with fluoride [method pharmaceuticals, llc]

Tri-Vite Drops with Fluroide 0_5 mg

Tri-vite drops with fluoride [method pharmaceuticals, llc]

Tri-Vite Drops with Fluroide 0_25 mg

Vistogard [wellstat therapeutics corporation]

These highlights do not include all the information needed to use VISTOGARD safely and effectively. See full prescribing information for VISTOGARD. VISTOGARD (uridine triacetate) oral granulesInitial U.S. Approval: 2015

Amoxicillin and clavulanate potassium [cambridge therapeutics technologies, llc]

These highlights do not include all the information needed to use AMOXICILLIN AND CLAVULANATE POTASSIUM, USP safely and effectively. See full prescribing information for AMOXICILLIN AND CLAVULANATE POTASSIUM, USP. AMOXICILLIN and CLAVULANATE Potassium Tab

Metformin hydrochloride [cambridge therapeutics technologies, llc]

Metformin Hydrochloride Tablets USP

Sodium fluoride [mayne pharma inc]

Sodium Fluoride Drops 0.5 mg Drops Peach Flavored

Ledipasvir and sofosbuvir [asegua therapeutics llc]

These highlights do not include all the information needed to use LEDIPASVIR and SOFOSBUVIR TABLETS safely and effectively. See full prescribing information for LEDIPASVIR and SOFOSBUVIR TABLETS. LEDIPASVIR and SOFOSBUVIR tablets, for oral useInitial U.S.

Naproxen [key therapeutics, llc]

Naproxen Oral Suspension, USP 125 mg/5 mL

Prevident fresh mint [colgate oral pharmaceuticals, inc.]

Colgate PreviDent Gel

Sf 5000 plus [cypress pharmaceutical, inc.]

SF 5000 Plus 1.1% Sodium Fluoride - Prescription Dental Cream

Sf [cypress pharmaceutical, inc.]

SF 1.1% Gel 1.1% Sodium Fluoride - Brush-On Gel

Sodium fluoride [method pharmaceuticals, llc]

Sodium Fluoride Drops

Qutenza [acorda therapeutics, inc.]

These highlights do not include all the information needed to use QUTENZA safely and effectively. See full prescribing information for QUTENZA. QUTENZA (capsaicin) 8% patch Initial U.S. Approval: 2009

Zanaflex [acorda therapeutics, inc.]

These highlights do not include all the information needed to use ZANAFLEX safely and effectively. See full prescribing information for ZANAFLEX. ZANAFLEX Capsules (tizanidine hydrochloride) capsules, for oral use ZANAFLEX (tizanidine hydrochloride) table

Abilify mycite [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use ABILIFY MYCITE safely and effectively. See full prescribing information for ABILIFY MYCITE. ABILIFY MYCITE (aripiprazole tablets with sensor), for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002



Advertisement
Quick Search
Advertisement
Advertisement